Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label free radicals. Show all posts
Showing posts with label free radicals. Show all posts

Tuesday, March 11, 2025

Free Radicals and Stroke

 You'll have to ask you competent? doctor to get this book; 'Role of Free Radicals in Pathology' and use it to get you recovered.

Free Radicals and Stroke


Friday, June 25, 2021

Curcumin Can Activate the Nrf2/HO-1 Signaling Pathway and Scavenge Free Radicals in Spinal Cord Injury Treatment

 Will this do the same for stroke? WHOM do we ask to do the followup? Specific names only. With NO LEADERSHIP AND NO STRATEGY NOTHING WILL BE DONE. Nothing on dosage or delivery method so you can't even guess how to accomplish this. Don't do this until 50 years from now when your doctor will have a prescription ready.

Curcumin Can Activate the Nrf2/HO-1 Signaling Pathway and Scavenge Free Radicals in Spinal Cord Injury Treatment

First Published May 13, 2021 Review Article Find in PubMed 

Spinal cord injury (SCI) is a devastating event that often leads to permanent neurological deficits. Evidence from emerging studies has implicated oxygen-derived free radicals and high-energy oxidants as mediators of secondary SCI. Therefore, targeting these mediators using antioxidants could be beneficial for the disease. Several signaling pathways, such as the nuclear factor erythroid-2-related factor 2/heme oxygenase 1 (Nrf2/HO-1), have been associated with the regulation of some pathophysiological features of SCI. Curcumin is a plant medicinal agent whose diverse pharmacological properties have been extensively investigated and reported, notably its ability to curtail inflammatory damage by inhibiting the nuclear factor-κ-light-chain-enhancer of activated B cells. In this review, we analyze the role of curcumin in activating Nrf2/HO-1 and scavenging free radicals to repair SCI. With its minimal side effects, curcumin could be a potential therapy for SCI treatment.

 

Tuesday, May 18, 2021

WHOM is going to research this for stroke and figure out how to get it across the blood brain barrier? Specific names only.

Curcumin Can Activate the Nrf2/HO-1 Signaling Pathway and Scavenge Free Radicals in Spinal Cord Injury Treatment

First Published May 13, 2021 Review Article 

Spinal cord injury (SCI) is a devastating event that often leads to permanent neurological deficits. Evidence from emerging studies has implicated oxygen-derived free radicals and high-energy oxidants as mediators of secondary SCI. Therefore, targeting these mediators using antioxidants could be beneficial for the disease. Several signaling pathways, such as the nuclear factor erythroid-2-related factor 2/heme oxygenase 1 (Nrf2/HO-1), have been associated with the regulation of some pathophysiological features of SCI. Curcumin is a plant medicinal agent whose diverse pharmacological properties have been extensively investigated and reported, notably its ability to curtail inflammatory damage by inhibiting the nuclear factor-κ-light-chain-enhancer of activated B cells. In this review, we analyze the role of curcumin in activating Nrf2/HO-1 and scavenging free radicals to repair SCI. With its minimal side effects, curcumin could be a potential therapy for SCI treatment.

Access Options
 

Sunday, May 3, 2015

New research into health benefits of coffee

But why are you reading this from me? Go ask your damned doctor. And this doesn't even mention my two main reasons for using it. 1. Helps me handle my stroke fatigue. 2.  Coffee May Lower Your Risk of Dementia

http://www.rdmag.com/news/2015/05/new-research-health-benefits-coffee?et_cid=4547254&et_rid=648870051&location=top

New research has brought us closer to being able to understand the health benefits of coffee.
Monash Univ. researchers, in collaboration with Italian coffee roasting company Illycaffè, have conducted the most comprehensive study to date on how free radicals and antioxidants behave during every stage of the coffee brewing process, from intact bean to coffee brew.
The team observed the behavior of free radicals—unstable molecules that seek electrons for stability and are known to cause cellular and DNA damage in the human body—in the coffee brewing process. For the first time, they discovered that under certain conditions coffee can act as an antioxidant, a compound found in foods that helps stabilize free radicals.
The findings, published in PLOS ONE, will lead to a deeper understanding of the brewing process, as well as the potential health benefits of coffee.
Chief Chemist of Illycaffè, Dr. Luciano Navarini, approached Monash physicist Dr. Gordon Troup, School of Physics and Astronomy, and his team in 2012 to conduct the research using state-of-the-art EPR (Electron Paramagnetic Resonance) Spectroscopy.
“Dr. Troup was one of the first scientists to discover free radicals in coffee in 1988 and so it made sense for Illycaffè—a world-leading coffee roasting company actively involved in coffee research—to collaborate with Dr. Troup and his team on this significant piece of research into free radical and antioxidant behavior in coffee,” Dr. Navarini said.
“The most important aim of this research was to better understand the development of stable free radicals during the roasting process and the possible influence exerted by developed radicals on the well-documented coffee antioxidant properties. We also wanted to evidence possible coffee constituents as a source of antioxidant activity.”
Dr. Troup worked with a team of researchers including Monash alumnus Dr. Simon Drew from the Univ. of Melbourne, who carried out the spectroscopy at the Univ. of Melbourne.
“Our research studied both the Arabica coffee bean itself and what happens to its stable free radical and antioxidant properties during the brewing process,” Dr. Troup said.
“The findings provide a better understanding of the potential health benefits of coffee, as well as a deeper knowledge of the roasting process—ultimately leading to the highest quality cup of coffee.”

Saturday, June 8, 2013

Drug found to reduce damage caused by heart attack and stroke

But, but, have they accounted for the fact that mouse inflammation is not the same as human inflammation? 

Drug found to reduce damage caused by heart attack and stroke


Research has found that a new drug can reduce the damage that heart attacks and strokes cause to the body.
Scientists at the Medical Research Council Mitochondrial Biology Unit inside Cambridge University found that a drug known as MitoSNO could repair tissue that has been starved of oxygen when running tests on mice.
After a heart attack, tissue can be damaged when blood flow is suddenly restored after a period without air.
Researchers believe MitoSNO has the power to turn off harmful molecules known as free radicals, which are produced during this process.
"MitoSNO effectively flicks a switch in the mitochondria, slowing down reactivation during those critical first minutes when blood flow returns and protecting the heart tissue from further damage," Dr Mike Murphy, who led the study, said.
He added that trials will need to be conducted on humans before anything conclusive can be stated, but if successful the drugs could be used in other areas of treatment.